BIOSITE DIAGNOSTICS INC
3, 1997-02-19
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: BIOSITE DIAGNOSTICS INC, SC 13D, 1997-02-19
Next: COLLECTIVE BANCORP INC, SC 13G, 1997-02-19



FORM 3


OMB APPROVAL
OMB NUMBER            3235-0104
EXPIRES:              APRIL 30, 1997
ESTIMATED AVERAGE
BURDEN HOURS PER
RESPONSE..............0.5


                 U.S. SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

            INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section
17(a) of the Public  Utility  Holding  Company  Act of 1935 or Section 30(f) of
the Investment Company Act of 1940


1.     Name and Address of Reporting Person

       MERCK KGAA
       FRANKFURTER STRASSE 250
       D-64293 DARMSTADT, GERMANY

2.     Date of Event Requiring Statement (Month/Day/Year)

       2/12/97

3.     IRS or Social Security Number of Reporting Person (Voluntary)

       N/A

4.     Issuer Name and Ticker or Trading Symbol

       BIOSITE DIAGNOSTICS INCORPORATED - BSTE

5.     Relationship of Reporting Person to Issuer (Check all applicable)

       ___ Director, ___ Officer (give title below),   <check> 10% Owner,
       ___ Other (specify below)

6.     If Amendment, Date of Original (Month/Day/Year)


TABLE I - NON-DERIVATIVE SECURITIES BENEFICIALLY OWNED

1.     Title of Security (Instr. 4)

       COMMON STOCK

2.     Amount of Securities Beneficially Owned (Instr. 4)

       1,187,667 SHARES

3.     Ownership Form:  Direct (D) or Inidrect (I)  (Instr. 5)

       D

4.     Nature of Indirect Beneficial Ownership (Instr. 5)


                                                                SEC 1473 (8/92)
<PAGE>

TABLE II - DERIVATIVE SECURITIES BENEFICIALLY OWNED (E.G., puts, calls,
warrants, options, convertible securities)

1.     Title of Derivative Security (Instr. 4)

       NO DERIVATIVE SECURITIES OWNED
2.     Date Exercisable and Expiration Date (Month/Day/Year):

       Date Exercisable:

       Expiration Date:

3.     Title and Amount of Securities Underlying Derivative Security (Instr. 4)

       Title:

       Amount or Number of Shares:

4.     Conver-sion or Exercise Price of Derivative Security

5.     Ownership Form of Derivative Security:  Direct (D) or Indirect (I)
       (Instr. 5)

6.     Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:  PRIOR TO THE AN INITIAL PUBLIC OFFERING ("IPO") AND
IN RELATION THERETO, THE ISSUER FILED FORM S-1 (FILE NO. 333-17657) WITH THE
S.E.C. ON DECEMBER 11, 1996 (EFFECTIVE DATE: FEB. 12, 1997). IMMEDIATELY PRIOR
TO THE IPO, MERCK KGAA WAS THE BENEFICIAL OWNER OF 1,041,667 SHARES OF COMMON
STOCK (APPROXIMATELY 8.8%) OF THE ISSUER, OBTAINED AS THE RESULT OF THE
AUTOMATIC CONVERSION OF ITS SERIES E PREFERRED STOCK INTO COMMON STOCK IN THE
IPO, PURSUANT TO THE STOCK PURCHASE AGREEMENT, DATED AS OF NOVEMBER 25, 1992,
BETWEEN THE ISSUER AND MERCK KGAA. IN THE COURSE OF THE IPO, MERCK KGAA
ACQUIRED AN ADDITIONAL 146,000 SHARES OF COMMON STOCK AT A PRICE OF $12.00 PER
SHARE DIRECTLY FROM THE ISSUER, THEREBY ACQUIRING IN THE AGGREGATE AN
APPROXIMATELY 10.5% OWNERSHIP POSITION IN THE ISSUER.  BOX 3 IS NOT APPLICABLE
BECAUSE THE REPORTING PERSON IS A GERMAN CORPORATION AND DOES NOT HAVE AN
I.R.S. NUMBER.

<TABLE>
<CAPTION>
<S>                                                 <C>                                <C>

** Intentional misstatements or                     /S/ KLAUS-PETER BRANDIS            2/17/97
   ommissions of facts constitute		    _______________________________    _______	
   Federal Criminal Violations.                     **Signature of Reporting Person      Date 
    				                    By: Klaus-Peter Brandis

</TABLE>


Note:  File three copies of this Form, one of which must be manually signed.
       If space provided is insufficient, SEE Instruction 6 for procedure.




                                                                         Page 2
                                                                SEC 1473 (8/92)




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission